$1.04 Billion is the total value of Opti Capital Management, LP's 43 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 61.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Sell | 8X8 INC NEWnote 0.500% 2/0 | $38,610,000 | -13.8% | 45,075,000 | -5.3% | 3.71% | +2.9% | |
| Sell | IONIS PHARMACEUTICALS INCnote 0.125%12/1 | $37,738,000 | -2.1% | 42,313,000 | -0.2% | 3.63% | +16.9% | |
| Sell | ENVESTNET INCnote 1.750% 6/0 | $28,245,000 | -22.0% | 28,000,000 | -6.7% | 2.72% | -6.8% | |
| Sell | DOCUSIGN INCnote 1/1 | $25,891,000 | -56.4% | 27,971,000 | -55.7% | 2.49% | -48.0% | |
| Sell | DICKS SPORTING GOODS INCnote 3.250% 4/1 | $14,726,000 | -84.1% | 6,155,000 | -79.2% | 1.42% | -81.0% | |
| Sell | FASTLY INCnote 3/1 | $12,852,000 | -66.0% | 17,500,000 | -65.0% | 1.24% | -59.4% | |
| Sell | COUPA SOFTWARE INCnote 0.125% 6/1 | $7,625,000 | -73.6% | 9,100,000 | -69.2% | 0.73% | -68.4% | |
| Exit | NEOGENOMICS INCnote 0.250% 1/1 | $0 | – | -1,500,000 | -100.0% | -0.08% | – | |
| Exit | COUPA SOFTWARE INCnote 0.375% 6/1 | $0 | – | -3,500,000 | -100.0% | -0.24% | – | |
| Exit | VIAVI SOLUTIONS INCnote 1.000% 3/0 | $0 | – | -3,096,000 | -100.0% | -0.32% | – | |
| Exit | OMEROS CORPnote 6.250%11/1 | $0 | – | -6,100,000 | -100.0% | -0.46% | – | |
| Exit | PTC THERAPEUTICS INCnote 3.000% 8/1 | $0 | – | -8,000,000 | -100.0% | -0.66% | – | |
| Exit | KARYOPHARM THERAPEUTICS INCnote 3.000%10/1 | $0 | – | -11,460,000 | -100.0% | -0.77% | – | |
| Exit | NEOGENOMICS INCnote 1.250% 5/0 | $0 | – | -15,750,000 | -100.0% | -1.09% | – | |
| Exit | AVAYA HLDGS CORPnote 2.250% 6/1 | $0 | – | -25,792,000 | -100.0% | -2.04% | – | |
| Exit | MANDIANT INCnote 1.625% 6/0 | $0 | – | -36,309,000 | -100.0% | -2.92% | – | |
| Exit | SAILPOINT TECHNOLOGIES HLDGSnote 0.125% 9/1 | $0 | – | -32,030,000 | -100.0% | -4.79% | – | |
| Exit | CONMED CORPnote 2.625% 2/0 | $0 | – | -50,065,000 | -100.0% | -6.97% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SUPERNUS PHARMACEUTICALS INC | 14 | Q1 2023 | 6.9% |
| NEW RELIC INC | 14 | Q1 2023 | 7.6% |
| 8X8 INC NEW | 13 | Q3 2023 | 7.4% |
| MANDIANT INC | 12 | Q1 2022 | 9.9% |
| NUTANIX INC | 12 | Q4 2022 | 7.3% |
| OPKO HEALTH INC | 12 | Q3 2023 | 2.1% |
| INSIGHT ENTERPRISES INC | 10 | Q3 2023 | 5.6% |
| ALTERYX INC | 10 | Q3 2023 | 4.6% |
| IONIS PHARMACEUTICALS INC | 10 | Q1 2023 | 3.6% |
| MODEL N INC | 10 | Q3 2023 | 1.7% |
View Opti Capital Management, LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
View Opti Capital Management, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.